|
CN101748145A
|
|
Recombinant yeast for expressing antibody or antibody analogue as well as construction method and application thereof
|
|
CN101413002A
|
|
Recombinant Kluyveromyces sp. expressing antibody or antibody analogue, and construction method and use thereof
|
|
CN101402961A
|
|
Method for producing glucoprotein vaccine
|
|
CN101366718A
|
|
Uses of 7-hydroxide radical-star shaped spore native in preparing medicament for treating virus hepatitis
|
|
WO2008011799A1
|
|
NEW USE OF NON-RECEPTOR TYROSINE KINASE c-Ab1 SPECIFIC INHIBITORS
|
|
CN1969856A
|
|
Usage of caffeine and its analogue in resistance of hepatitis B replication and use thereof in preparation of medicament for treating viral hepatitis
|
|
CN1884500A
|
|
Omega-3-aliphatic acid desaturase, and its encoding gene and use thereof
|
|
CN1880449A
|
|
Low molecular-weight urokinase mutant and its expression vector
|
|
CN1824296A
|
|
Use of cone shell polypeptide derivative in preparation of drug abstaining medicine
|
|
CN1772296A
|
|
New use of prophymosin-alpha
|
|
CN1772884A
|
|
Culture medium without animal originating component and serum for HEK293 cell adhesion culture
|
|
CN1733807A
|
|
Fusion protein possessing growth facilitation action and its coding gene and uses
|
|
CN1718587A
|
|
Ant CD20 chimeric antibody
|
|
CN1876179A
|
|
Use of protein YaeT in preparing immunological formulation and vaccine
|
|
CN1876180A
|
|
Use of protein TolC in preparing immunological formulation and vaccine
|
|
CN1806848A
|
|
Novel use of thymosin alpha protogene
|
|
CN1651075A
|
|
Therapeutic application of cone shell toxin SO3
|
|
CN1706954A
|
|
Construction process of pig serum albumin locus targeting vector for producing foreign protein
|
|
CN1556204A
|
|
Anti prourokinase monoclonal antibody hybrid oma cell line and its application
|
|
CN1556199A
|
|
Large scale high density culturing method saussurea involucrata cell line TUIP-8 of stable high yield flavone
|
